Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Receivables (2021 - 2025)

Core Scientific's Receivables history spans 5 years, with the latest figure at $1.0 million for Q1 2025.

  • For Q1 2025, Receivables fell 8.04% year-over-year to $1.0 million; the TTM value through Mar 2025 reached $1.0 million, down 8.04%, while the annual FY2024 figure was $1.0 million, 2.4% up from the prior year.
  • Receivables for Q1 2025 was $1.0 million at Core Scientific, down from $1.0 million in the prior quarter.
  • Across five years, Receivables topped out at $6.2 million in Q3 2024 and bottomed at $175000.0 in Q1 2023.
  • The 5-year median for Receivables is $1.1 million (2024), against an average of $2.0 million.
  • The largest annual shift saw Receivables plummeted 84.72% in 2022 before it surged 532.57% in 2024.
  • A 5-year view of Receivables shows it stood at $1.7 million in 2021, then tumbled by 84.72% to $257000.0 in 2022, then surged by 289.49% to $1.0 million in 2023, then increased by 2.4% to $1.0 million in 2024, then fell by 0.68% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Receivables are $1.0 million (Q1 2025), $1.0 million (Q4 2024), and $6.2 million (Q3 2024).